Treating kidney disease GLP-1s show higher risk than SGLT2 inhibitors in kidney outcomes, but lower albuminuria and mortality rates.
Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a hormone called glucose-dependent insulinotropic polypeptide (GIP) to “help break ...
Are Diabetes Drugs Really Safe (& Reliable) for Weight Loss? There’s been lots of attention on type 2 diabetes drugs recently, especially since they might also be able to support weight loss. Whether ...
A 2025 study suggests that metformin — a widely used treatment for type 2 diabetes — may also be associated with longer life ...
A long-term US study links metformin to 30% lower risk of dying before 90 in women with type 2 diabetes – is this the real longevity pill?
GLP-1RA drugs may lower risk of deadly subarachnoid haemorrhage strokes in diabetes patients.
News-Medical.Net on MSN
How GLP-1 drugs affect the body beyond weight loss and glucose control
By Tarun Sai Lomte Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks, and what clinicians should monitor long term. Review: ...
Now, it’s worth noting Stock Advisor’s total average return is 889 % — a market-crushing outperformance compared to 193% for the S&P 500. Don't miss the latest top 10 list, available with Stock ...
Share on Pinterest A new study found that certain diabetes medications could help lower the risk of neurodegenerative diseases. FG Trade/Getty Images A team of scientists in Korea recently ...
The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable semaglutide, the active ingredient in weight loss juggernauts Wegovy and ...
District officials say the decision will save $12 million and will put Broward in line with other school districts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results